Skip to main content
Top
Published in: Endocrine 1/2014

01-09-2014 | Original Article

Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects

Authors: A. Giandalia, G. T. Russo, E. L. Romeo, A. Alibrandi, P. Villari, A. A. Mirto, G. Armentano, S. Benvenga, D. Cucinotta

Published in: Endocrine | Issue 1/2014

Login to get access

Abstract

Although several observations indicate that serum TSH levels in the high normal range are related to cardiovascular (CVD) risk factors in the general population, similar data are limited in diabetic subjects. The aim of this study was to investigate the potential associations between TSH serum levels within the normal range and major metabolic and non-metabolic CVD risk factors in a cohort of euthyroid type 2 diabetic subjects. Thyroid hormones, TSH levels, anthropometric parameters, lipid profile, glucose control, and blood pressure were measured in 490 euthyroid type 2 diabetic subjects, consecutively attending two outpatient diabetic units in Southern Italy. In all subjects, we also calculated the Visceral Adiposity Index (VAI), an obesity-related index associated with CVD risk. Diabetic women showed higher mean serum TSH levels and lower FT4 concentration than diabetic men, while FT3 levels were comparable in the two genders. Stratifying the study population according to quartiles of TSH levels, subjects in the highest TSH quartile were more likely to be female and younger, with higher values of BMI and waist circumference (P = 0.05 both), higher triglycerides (P = 0.002) and non-HDL cholesterol concentrations (P = 0.01), higher VAI values (P = 0.02), and lower FT4 levels (P = 0.05), when compared to those in the lowest quartile. At multivariate analysis, a younger age, female gender, triglycerides levels, and waist circumference were independently associated with higher TSH levels. In conclusion, in type 2 diabetic subjects with no evidence of thyroid disease, higher TSH concentrations within the normal range were more frequent in women and in younger subjects, and they were associated with visceral obesity and higher triglycerides concentrations, two well-known CVD risk factors.
Literature
1.
go back to reference R. Kadiyala, R. Peter, O.E. Okosieme, Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int. J. Clin. Pract. 64(8), 1130–1139 (2010)PubMedCrossRef R. Kadiyala, R. Peter, O.E. Okosieme, Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int. J. Clin. Pract. 64(8), 1130–1139 (2010)PubMedCrossRef
2.
go back to reference S.A. Chubb, W.A. Davis, Z. Inman, T.M. Davis, Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin. Endocrinol. (Oxf) 62, 480–486 (2005)CrossRef S.A. Chubb, W.A. Davis, Z. Inman, T.M. Davis, Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin. Endocrinol. (Oxf) 62, 480–486 (2005)CrossRef
3.
go back to reference P. Perros, R.J. McCrimmon, G. Shaw, B.M. Frier, Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet. Med. 12, 622–627 (1995)PubMedCrossRef P. Perros, R.J. McCrimmon, G. Shaw, B.M. Frier, Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet. Med. 12, 622–627 (1995)PubMedCrossRef
4.
go back to reference L.H. Duntas, J. Orgiazzi, G. Brabant, The interface between thyroid and diabetes mellitus. Clin. Endocrinol. 75, 1–9 (2011)CrossRef L.H. Duntas, J. Orgiazzi, G. Brabant, The interface between thyroid and diabetes mellitus. Clin. Endocrinol. 75, 1–9 (2011)CrossRef
5.
go back to reference C. Wang, The relationship between type 2 diabetes mellitus and related thyroid diseases. J. Diabetes Res. 2013, 390534 (2013)PubMedCentralPubMed C. Wang, The relationship between type 2 diabetes mellitus and related thyroid diseases. J. Diabetes Res. 2013, 390534 (2013)PubMedCentralPubMed
6.
go back to reference A. Moura Neto, M.C. Parisi, M.A. Tambascia, E.J. Pavin, S.M. Alegre, D.E. Zantut-Wittmann, Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes. Endocrine. 2 Apr 2013 [Epub ahead of print] A. Moura Neto, M.C. Parisi, M.A. Tambascia, E.J. Pavin, S.M. Alegre, D.E. Zantut-Wittmann, Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes. Endocrine. 2 Apr 2013 [Epub ahead of print]
7.
go back to reference A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Subclinical hypothyroidism is a risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann. Intern. Med. 132(4), 270–278 (2000)PubMedCrossRef A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Subclinical hypothyroidism is a risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann. Intern. Med. 132(4), 270–278 (2000)PubMedCrossRef
8.
go back to reference R. Luboshitzky, A. Aviv, P. Herer, L. Lavie, Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12(5), 421–425 (2002)PubMedCrossRef R. Luboshitzky, A. Aviv, P. Herer, L. Lavie, Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12(5), 421–425 (2002)PubMedCrossRef
9.
go back to reference B.O. Asvold, L.J. Vatten, T.I. Nilsen, T. Bjøro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156, 181–186 (2007)PubMedCrossRef B.O. Asvold, L.J. Vatten, T.I. Nilsen, T. Bjøro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156, 181–186 (2007)PubMedCrossRef
10.
go back to reference B.O. Asvold, T. Bjøro, T.I. Nilsen, L.J. Vatten, Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J. Clin. Endocrinol. Metab. 92, 841–845 (2007)PubMedCrossRef B.O. Asvold, T. Bjøro, T.I. Nilsen, L.J. Vatten, Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J. Clin. Endocrinol. Metab. 92, 841–845 (2007)PubMedCrossRef
11.
go back to reference K. Saltiki, P. Voidonikola, K. Stamatelopoulos, E. Mantzou, C. Papamichael, M. Alevizaki, Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-selectional study. Thyroid Res. 1, 1–6 (2008)CrossRef K. Saltiki, P. Voidonikola, K. Stamatelopoulos, E. Mantzou, C. Papamichael, M. Alevizaki, Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross-selectional study. Thyroid Res. 1, 1–6 (2008)CrossRef
12.
go back to reference S. Ruhla, M.O. Weickert, A.M. Arafat, M. Osterhoff, F. Isken, J. Spranger, C. Schöfl, A.F. Pfeiffer, M. Möhlig, A high normal TSH is associated with the metabolic syndrome. Clin. Endocrinol. (Oxf) 72(5), 696–701 (2010)CrossRef S. Ruhla, M.O. Weickert, A.M. Arafat, M. Osterhoff, F. Isken, J. Spranger, C. Schöfl, A.F. Pfeiffer, M. Möhlig, A high normal TSH is associated with the metabolic syndrome. Clin. Endocrinol. (Oxf) 72(5), 696–701 (2010)CrossRef
13.
go back to reference H.T. Park, G.J. Cho, K.H. Ahn, J.H. Shin, S.C. Hong, T. Kim, J.Y. Hur, Y.T. Kim, K.W. Lee, S.H. Kim, Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 62(3), 301–305 (2009)PubMedCrossRef H.T. Park, G.J. Cho, K.H. Ahn, J.H. Shin, S.C. Hong, T. Kim, J.Y. Hur, Y.T. Kim, K.W. Lee, S.H. Kim, Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 62(3), 301–305 (2009)PubMedCrossRef
14.
go back to reference S.J. Bakker, J.C. ter Maaten, C. Popp-Snijders, J.P. Slaets, R.J. Heine, R.O. Gans, The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J. Clin. Endocrinol. Metab. 86(3), 1026–1031 (2001) S.J. Bakker, J.C. ter Maaten, C. Popp-Snijders, J.P. Slaets, R.J. Heine, R.O. Gans, The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J. Clin. Endocrinol. Metab. 86(3), 1026–1031 (2001)
15.
go back to reference S.A. Chubb, W.A. Davis, T.M. Davis, Interactions among thyroid function, insulin sensitivity and serum lipid concentrations: the Fremantle Diabetes study. J. Clin. Endocrinol. Metab. 90(9), 5317–5320 (2005)PubMedCrossRef S.A. Chubb, W.A. Davis, T.M. Davis, Interactions among thyroid function, insulin sensitivity and serum lipid concentrations: the Fremantle Diabetes study. J. Clin. Endocrinol. Metab. 90(9), 5317–5320 (2005)PubMedCrossRef
16.
go back to reference V. Lambadiari, P. Mitrou, E. Maratou, A.E. Raptis, N. Tountas, S.A. Raptis, G. Dimitriadis, Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine 39(1), 28–32 (2011)PubMedCrossRef V. Lambadiari, P. Mitrou, E. Maratou, A.E. Raptis, N. Tountas, S.A. Raptis, G. Dimitriadis, Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine 39(1), 28–32 (2011)PubMedCrossRef
17.
go back to reference S. Kouidhi, R. Berhouma, M. Ammar, K. Rouissi, S. Jarboui, M.S. Clerget-Froidevaux, I. Seugnet, H. Abid, F. Bchir, B. Demeneix, H. Guissouma, A.B. Elgaaied, Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects. Endocr. Res. 38(1), 15–23 (2013)PubMedCrossRef S. Kouidhi, R. Berhouma, M. Ammar, K. Rouissi, S. Jarboui, M.S. Clerget-Froidevaux, I. Seugnet, H. Abid, F. Bchir, B. Demeneix, H. Guissouma, A.B. Elgaaied, Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects. Endocr. Res. 38(1), 15–23 (2013)PubMedCrossRef
18.
go back to reference C. Cappelli, M. Rotondi, I. Pirola, B. Agosti, A. Formenti, E. Zarra, U. Valentini, P. Leporati, L. Chiovato, M. Castellano, Thyreotropin levels in diabetic patients on metformin treatment. Eur. J. Endocrinol. 167(2), 261–505 (2012)PubMed C. Cappelli, M. Rotondi, I. Pirola, B. Agosti, A. Formenti, E. Zarra, U. Valentini, P. Leporati, L. Chiovato, M. Castellano, Thyreotropin levels in diabetic patients on metformin treatment. Eur. J. Endocrinol. 167(2), 261–505 (2012)PubMed
19.
go back to reference J.J. Díez, P. Iglesias, Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin. Endocrinol. (Oxf) 78(4), 505–511 (2013)CrossRef J.J. Díez, P. Iglesias, Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin. Endocrinol. (Oxf) 78(4), 505–511 (2013)CrossRef
20.
go back to reference M.C. Amato, C. Giordano, M. Galia, A. Criscimanna, S. Vitabile, M. Midiri, A. Galluzzo, AlkaMeSy Study Group, Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4), 920–922 (2010)PubMedCentralPubMedCrossRef M.C. Amato, C. Giordano, M. Galia, A. Criscimanna, S. Vitabile, M. Midiri, A. Galluzzo, AlkaMeSy Study Group, Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4), 920–922 (2010)PubMedCentralPubMedCrossRef
21.
go back to reference M.C. Amato, C. Giordano, M. Pitrone, A. Galluzzo, Cut-off points of the visceraladiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 19(10), 183 (2011)CrossRef M.C. Amato, C. Giordano, M. Pitrone, A. Galluzzo, Cut-off points of the visceraladiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 19(10), 183 (2011)CrossRef
22.
go back to reference American Diabetes Association, Standards of medical care in diabetes. Diabetes Care 32(Suppl 1), 13–61 (2009) American Diabetes Association, Standards of medical care in diabetes. Diabetes Care 32(Suppl 1), 13–61 (2009)
23.
go back to reference W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed
24.
go back to reference F. Pesarin, Multivariate Permutation Test (Wiley, Chichester, 2001) F. Pesarin, Multivariate Permutation Test (Wiley, Chichester, 2001)
25.
go back to reference Soliani L, Manuale di statistica per la ricerca e la professione. Statistica univariata e bivariata parametrica e non-parametrica nelle discipline ambientali e biologiche. Uninova. (2004) Soliani L, Manuale di statistica per la ricerca e la professione. Statistica univariata e bivariata parametrica e non-parametrica nelle discipline ambientali e biologiche. Uninova. (2004)
26.
go back to reference Z. Baloch, P. Carayon, B. Conte-Devolx, L.M. Demers, U. Feldt-Rasmussen, J.F. Henry, V.A. LiVosli, P. Niccoli-Sire, R. John, J. Ruf, P.P. Smyth, C.A. Spencer, J.R. Stockigt, Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines, Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13(1), 3–126 (2003)PubMedCrossRef Z. Baloch, P. Carayon, B. Conte-Devolx, L.M. Demers, U. Feldt-Rasmussen, J.F. Henry, V.A. LiVosli, P. Niccoli-Sire, R. John, J. Ruf, P.P. Smyth, C.A. Spencer, J.R. Stockigt, Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines, Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13(1), 3–126 (2003)PubMedCrossRef
27.
go back to reference V. Ramasamy, R. Kadiyala, F. Fayyaz, A. Mallipedhi, P. Baglioni, O.E. Okosieme, Value of a baseline serum thyrotropin as a predictor of hypothyroidism in patients with diabetes. Endocr. Pract. 14, 1–25 (2010) V. Ramasamy, R. Kadiyala, F. Fayyaz, A. Mallipedhi, P. Baglioni, O.E. Okosieme, Value of a baseline serum thyrotropin as a predictor of hypothyroidism in patients with diabetes. Endocr. Pract. 14, 1–25 (2010)
28.
go back to reference J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988–1944) National Health and Nutrition Examination Survey. J. Clin. Endocrinol. Metab. 87, 489–499 (2002)PubMedCrossRef J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988–1944) National Health and Nutrition Examination Survey. J. Clin. Endocrinol. Metab. 87, 489–499 (2002)PubMedCrossRef
29.
go back to reference W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J.G. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickam survey. Clin. Endocrinol. (Oxf) 7, 481–493 (1997)CrossRef W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J.G. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickam survey. Clin. Endocrinol. (Oxf) 7, 481–493 (1997)CrossRef
30.
go back to reference F. Magri, L. Muzzoni, M. Cravello, M. Fioravanti, L. Busconi, D. Camozzi, G. Vignati, E. Ferrari, Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism 51(1), 105–109 (2002)PubMedCrossRef F. Magri, L. Muzzoni, M. Cravello, M. Fioravanti, L. Busconi, D. Camozzi, G. Vignati, E. Ferrari, Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism 51(1), 105–109 (2002)PubMedCrossRef
31.
go back to reference S. Mariotti, C. Franceschi, A. Cossarizza, A. Pinchera, The aging thyroid. Endocr. Rev. 16(6), 686–715 (1995)PubMedCrossRef S. Mariotti, C. Franceschi, A. Cossarizza, A. Pinchera, The aging thyroid. Endocr. Rev. 16(6), 686–715 (1995)PubMedCrossRef
32.
go back to reference S. Razvi, A. Shakoor, M. Vanderpump, J.U. Weaver, S.H. Pearce, The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J. Clin. Endocrinol. Metab. 8, 2998–3007 (2008)CrossRef S. Razvi, A. Shakoor, M. Vanderpump, J.U. Weaver, S.H. Pearce, The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J. Clin. Endocrinol. Metab. 8, 2998–3007 (2008)CrossRef
33.
go back to reference B. Mohammadreza, H. Farzad, K. Davoud, A.F. Fereidoun, Prognostic significance of the complex “Visceral Adiposity Index” vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc. Diabetol. 7(11), 20 (2012)CrossRef B. Mohammadreza, H. Farzad, K. Davoud, A.F. Fereidoun, Prognostic significance of the complex “Visceral Adiposity Index” vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc. Diabetol. 7(11), 20 (2012)CrossRef
34.
go back to reference J.J. Díez, P. Iglesias, Relationship between thyrotropin and body mass index in euthyroid subjects. Exp. Clin. Endocrinol. Diabetes 119, 144–150 (2011)PubMedCrossRef J.J. Díez, P. Iglesias, Relationship between thyrotropin and body mass index in euthyroid subjects. Exp. Clin. Endocrinol. Diabetes 119, 144–150 (2011)PubMedCrossRef
35.
go back to reference M. Nannipieri, F. Cecchetti, M. Anselmino, S. Camastra, P. Niccolini, M. Lamacchia, M. Rossi, G. Iervasi, E. Ferrannini, Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int. J. Obes. (Lond) 33(9), 1001–1006 (2009)CrossRef M. Nannipieri, F. Cecchetti, M. Anselmino, S. Camastra, P. Niccolini, M. Lamacchia, M. Rossi, G. Iervasi, E. Ferrannini, Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int. J. Obes. (Lond) 33(9), 1001–1006 (2009)CrossRef
36.
go back to reference G. Muscogiuri, G.P. Sorice, T. Mezza, A. Prioletta, A.P. Lassandro, T. Pirronti, S. Della Casa, A. Pontecorvi, A. Giaccari, High-normal TSH values in obesity: is it insulin resistance or adipose tissue’s guilt? Obesity (Silver Spring) 21, 101–106 (2013)CrossRef G. Muscogiuri, G.P. Sorice, T. Mezza, A. Prioletta, A.P. Lassandro, T. Pirronti, S. Della Casa, A. Pontecorvi, A. Giaccari, High-normal TSH values in obesity: is it insulin resistance or adipose tissue’s guilt? Obesity (Silver Spring) 21, 101–106 (2013)CrossRef
37.
go back to reference B.R. Tulloch, B. Lewis, T.R. Fraser, Triglyceride metabolism in thyroid disease. Lancet 1(7800), 391–394 (1973)PubMedCrossRef B.R. Tulloch, B. Lewis, T.R. Fraser, Triglyceride metabolism in thyroid disease. Lancet 1(7800), 391–394 (1973)PubMedCrossRef
38.
go back to reference A. Roos, S.J. Bakker, T.P. Links, R.O. Gans, B.H. Wolffenbuttel, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92(2), 491–496 (2007)PubMedCrossRef A. Roos, S.J. Bakker, T.P. Links, R.O. Gans, B.H. Wolffenbuttel, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92(2), 491–496 (2007)PubMedCrossRef
39.
go back to reference United Kingdom Prospective Diabetes Study 27, Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex (UKPDS 27) Diabetes Care 20(11), 1683–1687 (1997) United Kingdom Prospective Diabetes Study 27, Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex (UKPDS 27) Diabetes Care 20(11), 1683–1687 (1997)
40.
go back to reference B.G. Nordestgaard, M. Benn, P. Schnohr, A. Tybjaerg-Hansen, Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298(3), 299–308 (2007)PubMedCrossRef B.G. Nordestgaard, M. Benn, P. Schnohr, A. Tybjaerg-Hansen, Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298(3), 299–308 (2007)PubMedCrossRef
41.
go back to reference M. Triolo, A.J. Kwakernaak, F.G. Perton, R. de Vries, G.M. Dallinga-Thie, R.P. Dullaart, Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus. Atherosclerosis 228(2), 466–471 (2013)PubMedCrossRef M. Triolo, A.J. Kwakernaak, F.G. Perton, R. de Vries, G.M. Dallinga-Thie, R.P. Dullaart, Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus. Atherosclerosis 228(2), 466–471 (2013)PubMedCrossRef
Metadata
Title
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects
Authors
A. Giandalia
G. T. Russo
E. L. Romeo
A. Alibrandi
P. Villari
A. A. Mirto
G. Armentano
S. Benvenga
D. Cucinotta
Publication date
01-09-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0137-2

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue